• Home
  • Search Results
  • Cardiovascular effects of ethanol extract of Rubus chingii Hu (Rosaceae) in rats: an in vivo and in vitro approach.

Cardiovascular effects of ethanol extract of Rubus chingii Hu (Rosaceae) in rats: an in vivo and in vitro approach.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society (2014-06-17)
X H Su, R Duan, Y Y Sun, J F Wen, D G Kang, H S Lee, K W Cho, S N Jin
ABSTRACT

Rubus chingii Hu (Rosaceae) is an important traditional Chinese medicine that has been used to improve function of the kidney and treat excessive polyuria. However, the effects of Rubus chingii on the cardiovascular system and its pharmacological mechanisms of action have not been studied. The aim of the present study was to evaluate the cardiovascular effects of ethanol extract of Rubus chingii (ERC) in rats. The changes in systolic blood pressure and heart rate of rats and vascular tone of aortic rings in in vitro were measured using pressure transducer and force transducer, respectively, connected to a multichannel recording system. ERC decreased systolic blood pressure and heart rate in a concentration-dependent manner. ERC induced vasorelaxation in a concentration-dependent manner. The ERC-induced vasorelaxation was not observed in the absence of the endothelium. The vasorelaxant effect of ERC was significantly attenuated by inhibition of endothelial NO synthase (eNOS), soluble guanylyl cyclase (sGC), or Ca(2+) entry from extracellular sources with L-NAME, ODQ, diltiazem, or extracellular Ca(2+) depletion, respectively. Similarly, an inhibition of Akt with wortmannin attenuated the ERC-induced vasorelaxation. Modulators of the store-operated Ca(2+) entry, thapsigargin, Gd(3+), and 2-aminoethyl diphenylborinate markedly attenuated the ERC-induced vasorelaxation. Furthermore, 4-aminopyridine an inhibitor of voltage-dependent K(+) (KV) channel, significantly attenuated the ERC-induced vasorelaxation. However, tetraethylammonium and glibenclamide, had no significant effect on the ERC-induced vasorelaxation. Indomethacin, atropine, and propranolol had no effects on the ERC-induced vasorelaxation. The present study demonstrates that ERC induces vasorelaxation via endothelium-dependent two-step signaling: an activation of the Ca(2+)-eNOS-NO signaling in the endothelial cells and then subsequent stimulation of the NO-sGC-cGMP-KV channel signaling in the vascular smooth muscle cells. The Akt-eNOS pathway is also suggested to be involved in this relaxation. Also, the findings suggest that the ERC-induced vasorelaxation is closely related to the hypotensive action of the agent.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Indomethacin, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
Acetylcholine chloride, ≥99% (TLC)
Sigma-Aldrich
2-Aminoethyl diphenylborinate, 97%
Sigma-Aldrich
Tetraethylammonium chloride, ≥98% (titration)
Sigma-Aldrich
Atropine, ≥99% (TLC), powder
Sigma-Aldrich
4-Aminopyridine, 98%
Sigma-Aldrich
4-Aminopyridine, ≥99%
Supelco
Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Acetylcholine chloride, suitable for cell culture
Sigma-Aldrich
Gadolinium(III) chloride, anhydrous, powder, 99.99% trace metals basis
Sigma-Aldrich
Tetraethylammonium chloride, BioUltra, for molecular biology, ≥99.0% (AT)
Phenylephrine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Indomethacin, meets USP testing specifications
Sigma-Aldrich
(+)-cis-Diltiazem hydrochloride, ≥99% (HPLC)
USP
Diltiazem hydrochloride, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Acetylcholine chloride, pkg of 150 mg (per vial)
USP
Acetylcholine chloride, United States Pharmacopeia (USP) Reference Standard
USP
Indomethacin, United States Pharmacopeia (USP) Reference Standard
Atropine, European Pharmacopoeia (EP) Reference Standard
Indomethacin, European Pharmacopoeia (EP) Reference Standard
Acetylcholine chloride, European Pharmacopoeia (EP) Reference Standard
Diltiazem hydrochloride, European Pharmacopoeia (EP) Reference Standard
Supelco
Tetraethylammonium chloride, for electrochemical analysis, ≥99.0%
Supelco
4-Aminopyridine, PESTANAL®, analytical standard
Supelco
Gadolinium(III) chloride solution, NMR reference standard, water 1 %, DSS 0.1 %, 0.1 mg/mL in D2O (99.9 atom % D), NMR tube size 5 mm × 8 in.
Diltiazem for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Acetylcholine chloride, ≥99% (TLC), free-flowing, Redi-Dri
Atropine for peak identification, European Pharmacopoeia (EP) Reference Standard
Supelco
Atropine, analytical standard
Sigma-Aldrich
3-[(1R)-1-Hydroxy-2-(methylamino)ethyl]phenol, AldrichCPR